GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
A JAMA Psychiatry study indicates that individuals with eating disorders may misuse GLP-1 receptor agonists like Ozempic and Wegovy. These patients reported using weight loss injections at more than twice the rate of the general population. The research suggests these drugs may be used to sustain eating disorders.
What changed
New research data from JAMA Psychiatry identifies specific misuse rates among patients with eating disorders.
Live updates
-
Study Links GLP-1 Weight Loss Drug Misuse to Eating Disorders
confidence 100%A JAMA Psychiatry study indicates that individuals with eating disorders may misuse GLP-1 receptor agonists like Ozempic and Wegovy. These patients reported using weight loss injections at more than twice the rate of the general population. The research suggests these drugs may be used to sustain eating disorders.
What's confirmed:
- A study in JAMA Psychiatry found that people with eating disorders report using GLP-1 drugs at more than twice the rate of the general population.
- Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.
- GLP-1 receptor agonists include medications such as Ozempic and Wegovy.
Still unconfirmed:
- About 15% of adult women in the U.S. are currently using a GLP-1 drug.